[MO31] Mini-Oral Session 31　臨床試験推進プログラム1（Trial in Progress）

[MO31-4] Phase 1b/2 trial of tucatinib+trastuzumab+/-chemotherapy or pembrolizumab in patients with metastatic HER2+ GI cancers

^○設樂 紘平¹, NA NA², NA NA³, NA NA⁴, NA NA⁵, NA NA⁶, NA NA⁷, NA NA⁸, NA NA⁹, NA NA⁹, NA NA¹⁰ (1.国立がん研究センター東病院, 2.Washington University School of Medicine, 3.Mayo Clinic, 4.University of Colorado Cancer Center, 5.Cleveland Clinic, 6.Johns Hopkins Kimmel Cancer Center, 7.Stanford University School of Medicine, 8.University of Washington, 9.Seagen Inc, 10.Duke University Medical Center)